The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagement
L
Lara Perryman
A
Alison Findlay
J
Jana Baskar
B
Brett Charlton
J
Jonathan Foot
R
Ross Hamilton
D
Dieter Hamprecht
A
Amar Joshi
J
Jessica Stolp
C
Craig Turner
A
Amna Zahoor
W
Wenbin Zhou
B
Begoña López
S
Susana Ravassa
A
Arantxa González
W
Wolfgang Jarolimek
Article Details
Journal
Scientific Reports
Volume / Issue
Vol. 15, Issue 1
Published
July 02, 2025
ISSN
2045-2322
Publisher
Nature Portfolio
Authors (16)
L
Lara Perryman
A
Alison Findlay
J
Jana Baskar
B
Brett Charlton
J
Jonathan Foot
R
Ross Hamilton
D
Dieter Hamprecht
A
Amar Joshi
J
Jessica Stolp
C
Craig Turner
A
Amna Zahoor
W
Wenbin Zhou
B
Begoña López
S
Susana Ravassa
A
Arantxa González
W
Wolfgang Jarolimek
Related Articles from this Journal
AI models of unstable flow exhibit hallucination
Ramdhan Wibawa, Birendra Jha
Aug 2026
10.1038/s41598-026-64023-8
The MCAA-YOLO + XPBI integrated model provides a hybrid intelligent measurement method for predicting the body weight of Hu sheep
Hang Zhang, Yuang Cheng et al.
Aug 2026
10.1038/s41598-026-64075-w
Application of iron nano-biofertilizers as a sustainable approach to enhance growth and micronutrient uptake in soybean
Ava Mohrazi, Reza Ghasemi-Fasaei
Aug 2026
10.1038/s41598-026-66011-4
Adolescents’ status-dependent public and private conformity to prosocial and antisocial decisions in a public goods game
Niloofar Saeedi, Khatereh Borhani et al.
Aug 2026
10.1038/s41598-026-64831-y
An explainable hierarchical capsule network framework for supporting expert sensory evaluation of herbal medicines with natural language generation
Hyein Lee, Dae-Hyun Jung
Aug 2026
10.1038/s41598-026-64156-w